Peer-reviewedCC BYThe journal of gene medicine
CRISPR/Cas9‐Mediated Correction of the SLC25A38 Mutation in a Patient With Sideroblastic Anemia
- 1Shahid Chamran University of Ahvaz
- 2Jundishapur University of Medical Sciences
Related
- Comparison of Prime Editing and CRISPR-Cas Mediated HDR in Correcting CFTR-F508del Mutation in Patient iPSC-Derived Airway Basal Cells
- CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer
- SF3b inhibitors suppress proliferation of nonsmall cell lung cancer cells irrespective of EGFR mutation status
- Mutation of Drosophila Lsd1 Disrupts H3-K4 Methylation, Resulting in Tissue-Specific Defects during Development
- Lipid Composition in the Breast of Premenopausal BRCA1/2 Genetic Mutation Carriers Using MRI
BibTeX
@article{yazdanparast2026crisprcas9mediated,
title = {{CRISPR/Cas9‐Mediated Correction of the SLC25A38 Mutation in a Patient With Sideroblastic Anemia}},
author = {Shokoufeh Yazdanparast and Hamid Galehdari and SaeidReza Khatami and Elham Hoveizi and Kaveh Jaseb},
journal = {The journal of gene medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13662621},
note = {CC BY},
}
RIS
TY - JOUR
TI - CRISPR/Cas9‐Mediated Correction of the SLC25A38 Mutation in a Patient With Sideroblastic Anemia
AU - Shokoufeh Yazdanparast
AU - Hamid Galehdari
AU - SaeidReza Khatami
AU - Elham Hoveizi
AU - Kaveh Jaseb
PY - 2026
DA - 2026/10/01
JO - The journal of gene medicine
UR - https://europepmc.org/article/PMC/PMC13662621
SN - 1099-498X
SN - 1521-2254
ER -